These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction. Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207 [TBL] [Abstract][Full Text] [Related]
26. The metabolic syndrome: antecedent of adult cardiovascular disease in pediatrics. Cook S J Pediatr; 2004 Oct; 145(4):427-30. PubMed ID: 15480357 [No Abstract] [Full Text] [Related]
27. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function. Klaus JR; Hurwitz BE; Llabre MM; Skyler JS; Goldberg RB; Marks JB; Bilsker MS; Schneiderman N J Cardiometab Syndr; 2009; 4(2):63-71. PubMed ID: 19614791 [TBL] [Abstract][Full Text] [Related]
28. Is the metabolic syndrome a cardiovascular risk factor beyond its specific components? Inchiostro S; Fadini GP; de Kreutzenberg SV; Citroni N; Avogaro A J Am Coll Cardiol; 2007 Jun; 49(25):2465; author reply 2465-6. PubMed ID: 17599611 [No Abstract] [Full Text] [Related]
30. [Metabolic syndrome and cardiovascular risk in law machinery staffers]. Shogenova AB; El'garov AA; Murtazov AM; Shogenov AG Med Tr Prom Ekol; 2010; (11):7-12. PubMed ID: 21381302 [TBL] [Abstract][Full Text] [Related]
31. A complex constellation of interrelated conditions. Campbell ML Med Econ; 2009 Sep; 86(17):35-7. PubMed ID: 19806760 [No Abstract] [Full Text] [Related]
32. The psoriasis plot thickens. Weinberg JM Cutis; 2012 Sep; 90(3):112. PubMed ID: 23094305 [No Abstract] [Full Text] [Related]
33. The federal-provincial Canadian Heart Health Initiative. Canadian Heart Health Surveys Research Group. CMAJ; 1992 Jun; 146(11):1915-6. PubMed ID: 1596839 [No Abstract] [Full Text] [Related]
34. [Homocysteinemia and some other metabolic risk factors of cardiovascular pathology in adolescents with arterial hypotension]. Ust'iantseva IM; Khokhlova OI; Belogortseva EA; Protopopova GM Fiziol Cheloveka; 2004; 30(5):127-9. PubMed ID: 15526456 [No Abstract] [Full Text] [Related]
35. [Metabolic syndrome and prevention of cardiovascular diseases]. Zhao D; Liu J Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Dec; 27(12):1022-3. PubMed ID: 17415977 [No Abstract] [Full Text] [Related]
36. Prevention and control of risk factors among children and youth. Paradis G; McCrindle B Can J Cardiol; 1999 Dec; 15 Suppl G():25G-31G. PubMed ID: 10692654 [No Abstract] [Full Text] [Related]
37. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Dentali F; Squizzato A; Ageno W Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035 [TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome: nothing more than a constellation? Tikhonoff V; Casiglia E Eur Heart J; 2007 Apr; 28(7):780-1. PubMed ID: 17400607 [No Abstract] [Full Text] [Related]
39. Vascular consequences of metabolic syndrome in early life. Visseren FL Eur Heart J; 2008 Mar; 29(6):693-4. PubMed ID: 18308691 [No Abstract] [Full Text] [Related]
40. Does metabolic syndrome attenuate the advantages of being a young woman regarding the risk of cardiovascular disease? Turhan H; Yetkin E Int J Cardiol; 2007 Jan; 114(2):277-8. PubMed ID: 16600407 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]